Claversal

Claversal is a rectal formulation of mesalazine, used for managing inflammatory conditions in the lower gastrointestinal tract. This medication helps reduce inflammation and maintain remission. Ideal for targeted relief, Claversal is a trusted option for those seeking effective treatment.

Claversal, containing mesalazine, is primarily used for the treatment of inflammatory bowel diseases, particularly those affecting the rectum and lower colon. It is often prescribed to manage symptoms of ulcerative colitis and to help maintain remission. Mesalazine works by reducing inflammation in the digestive tract, providing relief from associated discomfort and promoting healing.

Common effects of Claversal may include mild abdominal cramps, diarrhea, or headaches. Some users might experience rectal irritation or discomfort. These effects are generally temporary and may subside as the body adjusts to the medication. If persistent or severe, consulting a healthcare provider is advisable.

Claversal should be used with caution in individuals with known allergies to mesalazine or related compounds. It is important to follow the prescribed dosage and administration instructions to minimize potential side effects. Always inform your healthcare provider about any existing medical conditions or medications you are taking before starting Claversal.

Claversal may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other bowel-related treatments. Alcohol consumption should be moderated, as it may exacerbate gastrointestinal side effects. Always consult a healthcare provider before combining Claversal with other medications to ensure safety and effectiveness.